Your shopping cart is currently empty

SMD-3040 is a potent and selective SMARCA2 PROTAC degrader that achieves efficient target protein elimination with a DC50 of 12 nM and a Dmax of 91%, leading to robust inhibition of tumor cell proliferation and pronounced antitumor activity, and is enabled by rational assembly of a SMARCA2/4 ligand and a VHL ligand, supporting its application in melanoma and broader oncology research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SMD-3040 is a potent and selective SMARCA2 PROTAC degrader that achieves efficient target protein elimination with a DC50 of 12 nM and a Dmax of 91%, leading to robust inhibition of tumor cell proliferation and pronounced antitumor activity, and is enabled by rational assembly of a SMARCA2/4 ligand and a VHL ligand, supporting its application in melanoma and broader oncology research. |
| In vitro | In proliferation assays utilizing SMARCA4-deficient cancer cell lines (specifically SK-Mel-5, H838, and A549), SMD-3040 was administered over a 7-day treatment period. The compound exhibited potent antiproliferative effects with GI50 values ranging from 8.8 to 119 nM [1]. |
| In vivo | To evaluate antitumor efficacy in a physiological context, a mouse model harboring human melanoma xenografts was employed. SMD-3040 was administered intravenously at dosages ranging from 25 to 50 mg/kg, following a schedule of twice-weekly injections for a duration of two weeks. This treatment regimen led to a significant suppression of tumor growth in the xenograft model [1]. |
| Synonyms | SMD3040, SMD 3040 |
| Molecular Weight | 943.21 |
| Formula | C52H66N10O5S |
| Cas No. | 3033109-92-8 |
| Smiles | C(N1CC2(C1)CCC(CC2)N3C=C(C=N3)C=4C=C(N=NC4N)C5=C(O)C=CC=C5)[C@H]6CC[C@H](C(N[C@H](C(=O)N7[C@H](C(N[C@@H](C)C8=CC=C(C=C8)C9=C(C)N=CS9)=O)C[C@@H](O)C7)C(C)(C)C)=O)CC6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (84.82 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.